✦ LIBER ✦

Pre-transplant serum creatinine predicts long-term outcome in pediatric heart transplant patients

✍ Scribed by Joseph W. Rossano; William J. Dreyer; Jeffrey J. Kim; Jack F. Price; Sarah K. Clunie; Mousumi Moulik; Jaime A. Decker; John P. Breinholt; E. Dean McKenzie; Susan W. Denfield; Jeffrey A. Towbin; John L. Jefferies

Book ID: 113861241
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 141 KB
Volume: 24
Category: Article
ISSN: 1058-9813
DOI: 10.1016/j.ppedcard.2007.08.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

165: Pre-Transplant Smoking in Heart Tra

165: Pre-Transplant Smoking in Heart Transplant Patients: A Marker for Long Term Outcome?

✍ E. Moreno; A. Velleca; C. Burch; J. Patel; M. Kittleson; M. Kawano; S. Davis; J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Long-term follow-up of pediatric heart t

Long-term follow-up of pediatric heart transplant patients

✍ Stephen R. Daniels 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Long-term outcomes in pediatric transpla

Long-term outcomes in pediatric transplantation

✍ O.N Fernando 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Long-term outcome of alternate list hear

Long-term outcome of alternate list heart transplant patients

✍ H. Laks; F. Mitropoulos; J. Odim; J.K. Patel; A. Marquez; M. Plesa; B.T. Oeser; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Long-Term Outcome in Heart Transplant Pa

Long-Term Outcome in Heart Transplant Patients With Pretransplant Malignancies

✍ C. Fernández-Vivancos; M.J. Paniagua-Martín; R. Marzoa-Rivas; E. Barge-Caballero 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Long-term outcomes in pediatric liver tr

Long-term outcomes in pediatric liver transplantation

✍ John Bucuvalas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

1. Critical clinical outcomes for pediatric liver transplantation (LT) recipients include (1) patient and graft survival, (2) complications (immune and nonimmune) of chronic immunosuppressive medications, and (3) long-term graft function. 2. Recurrence of malignancy, sepsis, and posttransplant lymph